Write For Us

Big pharma: GSK beats forecasts, but Novartis lags

Sponsored Post Vitamin D2 Canada Persia
53 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
GSK beat fourth-quarter profit and sales forecasts helped by sales of its shingles vaccine and unveiled an upbeat forecast for 2023. Meanwhile, Novartis said it’s full-year core operating income was broadly flat, and below expectations, at $16.7 billion.

#GSK #Novartis #News #Reuters #newsfeed #business #earnings

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, news, top news
Sign in or sign up to post comments.
Be the first to comment